Found: 5
Select item for more details and to access through your institution.
Efficacy of ravulizumab in patients with generalized myasthenia gravis by time from diagnosis: A post hoc subgroup analysis of the CHAMPION MG study.
- Published in:
- Muscle & Nerve, 2024, v. 69, n. 5, p. 556, doi. 10.1002/mus.28044
- By:
- Publication type:
- Article
Cardiorespiratory fitness does not alter plasma pentraxin 3 and cortisol reactivity to acute psychological stress and exercise.
- Published in:
- Applied Physiology, Nutrition & Metabolism, 2014, v. 39, n. 3, p. 375, doi. 10.1139/apnm-2013-0297
- By:
- Publication type:
- Article
Ravulizumab pharmacokinetics and pharmacodynamics in patients with generalized myasthenia gravis.
- Published in:
- Journal of Neurology, 2023, v. 270, n. 6, p. 3129, doi. 10.1007/s00415-023-11617-1
- By:
- Publication type:
- Article
Summary of Research: Terminal Complement Inhibitor Ravulizumab in Generalized Myasthenia Gravis.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Changes in serum collagen markers, IGF-I, and Knee joint laxity across the menstrual cycle.
- Published in:
- Journal of Orthopaedic Research, 2012, v. 30, n. 9, p. 1405, doi. 10.1002/jor.22093
- By:
- Publication type:
- Article